About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The aim of our group is to investigate the use of medicines and evaluate its benefit/risk relationship in usual clinical practice. Our group coordinates the Catalan centre of the Spanish System of Pharmacovigilance. Research activities on pharmacology and pharmacoepidemiology are coupled with undergraduate teaching at the Autonomous University of Barcelona Medical School, training of specialists in clinical pharmacology, and continuous education of health professionals on therapeutics.
The group is a Special Group of Research recognized by AGAUR GenCat. It is a partner of “The European Consortium “EU PE&PV Network” (European Pharmacoepidemiology and Pharmacovigilance Network)” and it is part of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). It gives institutional support to the Clinical Research Ethical Committee of the University hospital Vall d’Hebron (UHVH), the Drug and Pharmacotherapeutic Committee of the UHVH, and also to the Drug and Pharmacotherapeutic Committee of the Institut Català de la Salut.
PMID: 35256061 Journal: Endocrinologia Diabetes y Nutricion Year: 2022 Reference: Endocrinol Diabetes Nutr. 2022 Feb;69(2):155-156. doi: 10.1016/j.endien.2022.02.004. Impact factor: Publication type: Letter or abstract Authors: Ciudin, Andreea; Cordero-Vazquez, Efrain; Filippi-Arriaga, Francesca; Haman, Stephanie Solange Tasayco; Hernandez, Irene Hernandez et al. DOI: 10.1016/j.endinu.2020.11.008
PMID: 35134393 Journal: JOURNAL OF AFFECTIVE DISORDERS Year: 2022 Reference: J Affect Disord. 2022 Apr 15;303:131-137. doi: 10.1016/j.jad.2022.02.001. Epub 2022 Feb 5. Impact factor: Publication type: Paper in international publication Authors: Ballarin, E; Camacho-Arteaga, L F; Camacho-Arteaga, L F; Gardarsdottir, H; Hek, K; Ibanez, L; Sabate, M; Souverein, P C; van Dijk, L; Vidal, X et al. DOI: 10.1016/j.jad.2022.02.001
PMID: 35127085 Journal: Molecular and clinical oncology Year: 2022 Reference: Mol Clin Oncol. 2022 Mar;16(3):60. doi: 10.3892/mco.2022.2493. Epub 2022 Jan 12. Impact factor: Publication type: Letter or abstract Authors: Capdevila, Jaume; Garcia, Alejandro; Hernando, Jorge; Riera-Arnau, Judit; Roca, Maria et al. DOI: 10.3892/mco.2022.2493
PMID: 33846003 Journal: MEDICINA CLINICA Year: 2022 Reference: Med Clin (Barc). 2022 Feb 11;158(3):111-117. doi: 10.1016/j.medcli.2020.12.041. Epub 2021 Apr 9. Impact factor: Publication type: Paper in national publication Authors: Crespo-Fresno, Almudena; Cuxart-Fina, Ampar; Pages-Bolibar, Esther; Sanchez-Raya, Judith; Vidal-Guitart, Xavier et al. DOI: 10.1016/j.medcli.2020.12.041
PMID: 34181880 Journal: LANCET Year: 2021 Reference: Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Impact factor: Publication type: Paper in international publication Authors: Aguilar, Carla; Agusti, Antonia; Alcami, Jose; Aldea, Marta; Altadill, Carmen; Alvarez-Morales, Veronica; Andia, Joseba; Andres Galvan, Maria Elena; Andres Galvan, Maria Elena; Aparicio Marlasca, Marina et al. DOI: 10.1016/S0140-6736(21)01420-3
PMID: 34104210 Journal: Therapeutic Advances in Gastroenterology Year: 2021 Reference: Therap Adv Gastroenterol. 2021 May 30;14:17562848211016567. doi: 10.1177/17562848211016567. eCollection 2021. Impact factor: Publication type: Paper in international publication Authors: Aguilera-Castro, Lara; Alvarez-Lopez, Patricia; Anton, Adrian; Augustin, Salvador; Banares, Juan; Barber, Claudia; Barreira-Diaz, Ana; Biagetti, Betina; Campos-Varela, Isabel; Camps-Relats, Laura et al. DOI: 10.1177/17562848211016567
PMID: 33216993 Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY Year: 2021 Reference: Br J Clin Pharmacol. 2021 Jun;87(6):2549-2557. doi: 10.1111/bcp.14665. Epub 2020 Dec 3. Impact factor: Publication type: Paper in international publication Authors: Aguilera, Cristina; Agusti, Antonia; Aller, Marta B; Boixareu, Nuria; Bosch, Montserrat; Danes, Immaculada; Diogene, Eduard; Garcia-Dolade, Nuria; Perez, Eulalia; Vendrell, Lourdes et al. DOI: 10.1111/bcp.14665
PMID: 34025429 Journal: Frontiers in Pharmacology Year: 2021 Reference: Front Pharmacol. 2021 May 5;12:670945. doi: 10.3389/fphar.2021.670945. eCollection 2021. Impact factor: Publication type: Paper in international publication Authors: Agusti, Antonia; Alonso, Laura; Amaro-Hosey, Kristopher; Cereza, Gloria; Danes, Immaculada; Gros, Luis; Renedo, Berta; Vendrell, Lourdes; Vidal, Xavier et al. DOI: 10.3389/fphar.2021.670945
PMID: 31156839 Journal: European Journal of Hospital Pharmacy-Science and Practice Year: 2016 Reference: Eur J Hosp Pharm. 2016 May;23(3):161-165. doi: 10.1136/ejhpharm-2015-000770. Epub 2015 Oct 28. Impact factor: 0.432 Publication type: Paper in international publication Authors: Salat, D, Llop, R, Aguilera, C, Danes, I, Bosch, M, Asensio, C, Castaneda, F, Esterlich, E, Vallano, A et al. DOI: 10.1136/ejhpharm-2015-000770
PMID: 26707367 Journal: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY Year: 2016 Reference: Basic Clin Pharmacol Toxicol. 2016 Jul;119(1):3-9. doi: 10.1111/bcpt.12550. Epub 2016 Feb 3. Impact factor: 3.097 Publication type: Paper in international publication Authors: Ferrer, Pili, Amelio, Justyna, Ballarin, Elena, Sabate, Monica, Rottenkolber, Marietta, Schmiedl, Sven, Laporte, Joan-Ramon, Ibanez, Luisa, Vidal, Xavi et al. DOI: 10.1111/bcpt.12550
PMID: 26799344 Journal: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Year: 2016 Reference: Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):725-32. doi: 10.1002/pds.3967. Epub 2016 Jan 22. Impact factor: 2.908 Publication type: Paper in international publication Authors: Laporte, Joan-Ramon et al. DOI: 10.1002/pds.3967
PMID: 27151175 Journal: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY Year: 2016 Reference: Basic Clin Pharmacol Toxicol. 2016 Nov;119(5):476-484. doi: 10.1111/bcpt.12615. Epub 2016 May 25. Impact factor: 3.097 Publication type: Paper in international publication Authors: Villar, Maria M, Iavecchia, Lujan, Safiya, Ahmad, Salat, David, Sabate, Monica, Bosch, Montse, Biarnes, Alfons, Camps, Angels, Castella, Dolors, Lalueza, Pilar et al. DOI: 10.1111/bcpt.12615
PMID: 24875352 Journal: INT J PUBLIC HEALTH Year: 2014 Reference: Int J Public Health. 2014 Oct;59(5):877-87. doi: 10.1007/s00038-014-0564-8. Epub 2014 May 30. Impact factor: 1.966 Publication type: Paper in international publication Authors: Ferrer, Pili, Ballarin, Elena, Sabate, Monica, Laporte, Joan-Ramon, Schoonen, Marieke, Rottenkolber, Marietta, Fortuny, Joan, Hasford, Joerg, Tatt, Iain, Ibanez, Luisa et al. DOI: 10.1007/s00038-014-0564-8
PMID: 21762481 Journal: BMC GASTROENTEROLOGY Year: 2011 Reference: BMC Gastroenterol. 2011 Jul 15;11:80. Impact factor: 2.468 Publication type: Paper in international publication Authors: , , , , , , , , , et al. DOI: 10.1186/1471-230X-11-80
The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and years after treatment.
The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine
The study by physician Emilie Anderssen seeks to optimize the medicalization of people living in nursing homes.
